PMID: 9174185Jun 1, 1997Paper

Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice

Antimicrobial Agents and Chemotherapy
John ConleyJ P Wong

Abstract

The aerosol delivery of liposome-encapsulated ciprofloxacin by using 12 commercially available jet nebulizers was evaluated in this study. Aerosol particles containing liposome-encapsulated ciprofloxacin generated by the nebulizers were analyzed with a laser aerodynamic particle sizer. Mean mass aerodynamic diameters (MMADs) and geometric standard deviations (GSDs) were determined, and the drug contents of the sampling filters from each run onto which aerosolized liposome-encapsulated ciprofloxacin had been deposited were analyzed spectrophotometrically. The aerosol particles of liposome-encapsulated ciprofloxacin generated by these nebulizers ranged from 1.94 to 3.5 microm, with GSDs ranging from 1.51 to 1.84 microm. The drug contents of the sampling filters exposed for 1 min to aerosolized liposome-encapsulated ciprofloxacin range from 12.7 to 40.5 microg/ml (0.06 to 0.2 mg/filter). By using the nebulizer selected on the basis of most desirable MMADs, particle counts, and drug deposition, aerosolized liposome-encapsulated ciprofloxacin was used for the treatment of mice infected with 10 times the 50% lethal dose of Francisella tularensis. All mice treated with aerosolized liposome-encapsulated ciprofloxacin survived the infec...Continue Reading

References

Jul 1, 1991·Experimental Lung Research·R J Gonzalez-RothiH Schreier
Sep 1, 1991·Infection and Immunity·A H FortierC A Nacy
Nov 1, 1990·Antimicrobial Agents and Chemotherapy·R L AtmarR B Couch
Sep 1, 1988·Antiviral Research·B E GilbertV Knight
Feb 1, 1988·The American Review of Respiratory Disease·A B MontgomeryP C Hopewell
Jan 1, 1988·Antimicrobial Agents and Chemotherapy·R QuentinA Goudeau
Aug 1, 1988·The Journal of Infectious Diseases·V KnightG W Divine
Jan 1, 1984·Thorax·S W Clarke, S P Newman
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·N X Chin, H C Neu
Nov 1, 1993·Antimicrobial Agents and Chemotherapy·M MagallanesJ Fierer

❮ Previous
Next ❯

Citations

Jun 17, 2006·Pharmaceutical Research·Patrick Couvreur, Christine Vauthier
Nov 19, 2013·Pharmaceutical Patent Analyst·David Cipolla, Hak-Kim Chan
Jul 6, 2014·Frontiers in Cellular and Infection Microbiology·Karleigh A HamblinHelen S Atkins
Feb 22, 2017·Frontiers in Microbiology·Karleigh A HamblinHelen S Atkins
Feb 24, 2018·Future Medicinal Chemistry·Arcadia Woods, Khondaker Miraz Rahman
Oct 5, 2002·Clinical Microbiology Reviews·Jill EllisRichard W Titball
Aug 15, 2009·Expert Opinion on Drug Delivery·Paolo BlasiMaurizio Ricci
Aug 5, 2010·Journal of Microencapsulation·Esmaeil MoazeniHossein Jamalifar
Jun 7, 2013·Journal of Liposome Research·Saptarshi Chattopadhyay
Oct 14, 2014·BioMed Research International·Jaleh VarshosazAbodolreza Babaee
Jul 9, 2014·Antimicrobial Agents and Chemotherapy·I H NorvilleT P Atkins
Jan 25, 2020·PloS One·Chad W StratiloJames D Blanchard
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Irma A J M Bakker-WoudenbergJohan W Mouton
Jan 11, 2005·The Journal of Pharmacy and Pharmacology·Oselys Rodriguez Justo, Angela Maria Moraes
Apr 16, 2014·Frontiers in Cellular and Infection Microbiology·Sandrine BoissetMax Maurin
Mar 19, 2014·Antimicrobial Agents and Chemotherapy·Karleigh A HamblinHelen S Atkins
Mar 5, 2016·Pharmaceutics·David CipollaIgor Gonda
Jan 3, 2014·Risk Analysis : an Official Publication of the Society for Risk Analysis·Sondra S TeskeCharles N Haas
Mar 21, 2000·International Journal of Antimicrobial Agents·H Pinto-AlphandaryP Couvreur
Dec 13, 2003·Journal of Pharmacological and Toxicological Methods·Justin M Hartings, Chad J Roy
Jun 28, 2013·Molecular Pharmaceutics·Hui Xin OngPaul M Young
Jan 15, 2011·Annals of Clinical Microbiology and Antimicrobials·Shanping CaoMing Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.